« Back
Home /
IRAK inhibitor 4

IRAK inhibitor 4

Manufacturer	MedChem Express
Category	Oncology Neuroscience Neural Lineage Markers Metabolism Diabetes Glucose Homeostasis By Cell Type Hematology Lymphoma Inhibitors & Compound Libraries Small Molecules By Organ Heart & Blood Cancer Neurodegeneration Markers;Research Area Oncology By Cell Type Hematology Leukemia
Type	Inhibitors
Specific against	other
Amount	10mM*1 mL
Quantity options	10mM*1 mL 5 mg
Item no.	HY-13278-10mM
Targets	IRAK
CASRN	1012104-68-5
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	1012104-68-5
Purity	99.77
Product Description	IRAK inhibitor 4 is an interleukin-1 receptor associated kinase 4(IRAK4) inhibitor.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	620.66
Clinical_Information	No Development Reported
Manufacturers Research Area	Inflammation/Immunology
Solubility	DMSO : 12.5 mg/mL (ultrasonic)
Manufacturers Target	IRAK
Isoform	IRAK4
Pathway	Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-13278-10mM-safety-datasheet.pdf